Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Connective Tissue Diseases and Lung Manifestations Prospective Trial With Focus on Systemic Sclerosis (Colipris)

NCT04095351 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.

NCT NCT04095351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04095351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Connective Tissue Diseases and Lung Manifestations Prospective Trial With Focus on Systemic Sclerosis (Colipris)
Lead sponsor
Medical University Innsbruck
Phase
Observational
Overall status
Recruiting
Start date
December 9, 2019
Completion date
October 1, 2034
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

connective tissue diseases, interstitial lung disease, systemic sclerosis